Atlas Trials

Phase II Trial to Evaluate Safety and Immunogenicity of a Dengue 1,2,3,4 (Attenuated) Vaccine

Clinical trial NCT01696422 · UNKNOWN

Trial details

NCT number
NCT01696422
Sponsor
Butantan Institute
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Dengue
Start date
2013-10-01
Primary completion
2016-04-01
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.